Medical News Hubb
Advertisement
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
Medical News Hubb
No Result
View All Result
Home Pharmaceutical

Health Bulletin 10/September/2022

admin by admin
September 10, 2022
in Pharmaceutical



Here are the top health news for the day:

Pharma association gives clean chit to Dolo-maker
Maker of Dolo 650, Micro Labs which landed in controversy over alleged distribution of freebies to doctors has received a clean chit from the Indian Pharmaceutical Alliance (IPA).
Patanjali moves to court supporting PIL seeking Holistic Integrated Medicinal System for medical education and treatment

Supporting the Public Interest Litigation (PIL) seeking adoption of a “Holistic Integrated Medicinal System” in India, the Yoga Guru Baba Ramdev’s Patanjali Research Institute approached the Delhi High Court yesterday praying to become impleaded as a party in the petition.

Noting that the intervention application seeking impleadment in the petition was not on record, a bench of Chief Justice S C Sharma and S Prasad granted one week’s time to the applicant institute to bring it on record, adds PTI.

For more details, check out the link given below:

Patanjali Moves To Court Supporting PIL Seeking Holistic Integrated Medicinal System For Medical Education And Treatment

Researchers discover new type of technology to detect ovarian cancer

A new type of technology can capture stray ovarian cancer cells from a simple blood test and successfully predict cancer in people who have a lesion or cyst in the pelvic region, according to a new study by a Wilmot Cancer Institute physician/scientist.

Nearly 200 local people participated in the study, which was led by Richard Moore, M.D., director of the Wilmot Cancer Institute’s Gynecologic Oncology program at the University of Rochester Medical Center. Results were published on Sept. 8, 2022, in the high-impact Obstetrics & Gynecology “Green” journal.

Reference:

Moore, Richard George MD et al , Malignancy Assessment Using Gene Identification in Captured Cells Algorithm for the Prediction of Malignancy in Women With a Pelvic Mass, Obstetrics and Gynecology, sep 2022 DOI: 10.1097/AOG.0000000000004927

NBE invites applications for FMGE December 2022, check out eligibility criteria, schedule, fee, complete details here

Through a recent notice, the National Board of Examinations (NBE) has invited Applications for Foreign Medical Graduate Examination (FMGE) December 2022.

National Board of Examinations in Medical Sciences (NBEMS) shall conduct the FMGE December 2022 on 4th December 2022 on a Computer Based Platform at various test centres across the country.

Application form for FMGE December 2022 can only be submitted online at https://nbe.edu.in from 9th September 2022 (3 PM Onwards) to 29th September 2022 (Till 11:55 PM).

For more details, check out the link given below:
NBE Invites Applications For FMGE December 2022, Check Out Eligibility Criteria, Schedule, Fee, Complete Details Here

COVID drug: Zenara Pharma unveils generic of Pfizer Paxlovid at Rs 5,200 per box in india

Hyderabad-based Zenara Pharma, a fully owned subsidiary of Biophore India Pharmaceuticals, has announced that the company has launched Nirmatrelvir and Ritonavir tablets in a combi pack as a treatment option for patients with mild to moderate symptoms of Covid-19.

It is to be noted that Zenara Pharma has received approval from the Central Drugs Standard Control Organization (CDSCO) to manufacture and market this product last month. The tablet, which will be sold under the brand name ‘Paxzen’, is being manufactured at Zenara’s USFDA and EU approved state-of-the-art facility in Hyderabad.

For more details, check out the link given below:

COVID Drug: Zenara Pharma Unveils Generic Of Pfizer Paxlovid At Rs 5,200 Per Box In India

Revisit decision on Govt fees for 50 percent private medical colleges seats, issue fresh OM if necessary: Madras HC tells NMC

Amid all the ongoing litigations concerning the National Medical Commission’s order regarding Government fees in 50 percent medical seats in the private medical colleges, the Madras High Court bench has directed the NMC to reconsider its decision in this regard.

Although the High Court bench comprising of Chief Justice Munishwar Nath Bhandari and Justice N. Mala has upheld the constitutional validity of Section 10 (1) (i) of the NMC Act 2019, under which the concerned office memorandum was issued, it expressed its concern over the possibility of several seats going vacant because of the high fees in the other 50 percent seats in the self-financed institutes.

For more details, check out the link given below:

Revisit Decision On Govt Fees For 50 Percent Private Medical Colleges Seats, Issue Fresh OM If Necessary: Madras HC Tells NMC



Source link

Tags: Baba RamdevBiophore India Pharmablood testcancerCDSCOcoronavirusCOVID drugcovid19Delhi High Courtdolodolo 650feeFMGEFMGE December 2022Foreign Medical Graduate ExaminationHolistic Integrated Medicinal SystemIndian Pharmaceutical AllianceMadras High Courtmedical college seatMicro Labsmicro labs newsNational Board of ExaminationsNational Medical CommissionNBENirmatrelvir tabletNMCObstetrics & Gynecology Green journalovarian cancerPatanjaliPatanjali Research InstitutePaxlovidPaxzenpfizerprivate medical collegesRitonavir tabletWilmot Cancer InstituteYoga GuruZenara PharmaZenara Pharma news
Previous Post

AHA Statement on the Effects of Loneliness, Isolation on Cardiovascular Health

Next Post

Boston’s most valuable biotech? It’s not who you might expect

Next Post

Boston’s most valuable biotech? It’s not who you might expect

Recommended

Invitae’s new CEO on genetic testing firm’s struggles and future

January 16, 2023

Keeping Your Laundry Free From Monkeypox

August 8, 2022

Don't miss it

Pharmaceutical

ALS Association battles its chapters over money, priorities

February 3, 2023
Medicines & Healthy Lifestyle

Surgery and Prescriptions Now Advised for Obese Children?

February 3, 2023
Medicines & Healthy Lifestyle

Jesduvroq Approved for Anemia of CKD in Patients on Dialysis

February 3, 2023
Medicines & Healthy Lifestyle

Prescribing Medication Dosage According To DNA Profile Lowers Side Effects By 30%: Study

February 3, 2023
News

Longer Diabetes Duration Links With Increased Heart Failure

February 3, 2023
Pharmaceutical

Health Bulletin 3/ February/ 2023

February 3, 2023

© 2022 Medical News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

Newsletter Sign Up

No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

© 2022 Medical News Hubb All rights reserved.